The LIPA gene gives your body instructions to make an enzyme that breaks down certain stored fats and cholesterol inside cells. When both copies of this gene do not work properly, these fats can build up and may lead to liver and spleen enlargement, feeding or stomach problems, poor growth, and abnormal cholesterol levels. This gene plays an important role in how your body handles fats from food and from its own stores. In medicine, harmful variants in the LIPA gene are linked to lysosomal acid lipase deficiency, a rare inherited condition that can range from infant-onset disease to milder forms found later in life.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes carry the directions for producing proteins, the functional parts of cells. Other genes mainly control when certain processes take place, where they take place, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
LIPAGene function
What if the gene works
The LIPA gene makes an enzyme that breaks down certain fats inside lysosomes, the cell’s recycling centers. This helps cells handle cholesterol and triglycerides and helps prevent fat buildup, especially in the liver and other tissues.
Risk
What if the gene does not work
More severe variants in the LIPA gene can cause infant illness with poor growth, vomiting, and liver enlargement. Milder variants often lead later to fatty liver, high cholesterol, and spleen enlargement. Symptoms and timing can vary.
Treatment
What does that mean for your treatment
A pathogenic loss-of-function variant in the LIPA gene can support use of enzyme replacement therapy with sebelipase alfa, the established treatment matched to this condition. This treatment replaces the missing enzyme and can improve liver measures, blood fats, growth, and survival, especially when started early.
Conditions associated with LIPA
Gene function
What if the gene works
Inside many cells, fat-rich particles are taken apart in a careful, stepwise way. Your cells rely on the LIPA gene to process certain fats once they reach lysosomes, the cell's recycling compartments. This helps release cholesterol and fatty acids for routine cell work and supports how the body handles fats day to day.
The LIPA gene provides instructions for an enzyme that breaks down stored cholesterol and triglycerides inside lysosomes. This turns packaged fats into smaller parts your cells can use.
After fat-rich particles enter a cell, the LIPA gene helps free cholesterol from its stored form. Cells can then use it in cell membranes or adjust how they handle cholesterol day to day.
The enzyme made from the LIPA gene also releases fatty acids from triglycerides. These fatty acids can be used for energy or reused to build other fats your body needs.
LIPA works inside lysosomes, which are the recycling compartments of the cell. This is part of how the LIPA gene helps break down fats in cells after they arrive from the bloodstream.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
When looking at how variants in the LIPA gene affect function, the key issue is how much lysosomal acid lipase activity remains. Some variants leave part of the enzyme working, while more severe variants can make the protein unstable, misfolded, poorly delivered to the lysosome (the cell’s recycling compartment), or cut short, so activity is very low or absent. This range often shapes whether lysosomal acid lipase deficiency appears later and more mildly or begins earlier with broader effects.
How variants are linked to conditions
Pathogenic variants in the LIPA gene cause lysosomal acid lipase deficiency, a rare inherited condition that can begin in infancy or later in life. In babies, it may appear as the severe form historically called Wolman disease, while older children and adults may have the milder form historically called cholesteryl ester storage disease. In practice, these are now viewed as part of one lysosomal acid lipase deficiency spectrum linked to the LIPA gene.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For LIPA, risk is mainly set by inheritance rather than lifestyle. A child is at higher risk only if both parents carry a changed LIPA gene, and the chance is higher in families with a known history of this condition.
Inheritance of LIPA variants
LIPA-related conditions are inherited in an autosomal recessive pattern. This means a child usually needs to inherit two altered copies of the LIPA gene, one from each parent, to have lysosomal acid lipase deficiency. Parents who each carry one LIPA gene variant are often unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is also a carrier, and a 25% chance of having a child with two working copies. This is the usual pattern doctors mean when discussing how LIPA gene variants are inherited.
What does my LIPA result mean for my family?
For LIPA, family members can be affected even when parents are healthy carriers. Brothers and sisters of someone with a disease-causing LIPA result may also have the condition or be carriers, and close relatives may wish to learn whether the variant runs in the family. This can be especially relevant for relatives planning children, because two carriers can pass the condition on to a child.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the LIPA gene, clinicians use LIPA genetic testing with a blood or saliva sample. A lab reads the DNA code to look for variants, and results can help confirm lysosomal acid lipase deficiency or show whether someone in a family carries the condition.
When should I consider getting a genetic test?
Testing for changes in the LIPA gene may be worth considering if there is a family history of a rare condition called lysosomal acid lipase deficiency, or if someone has ongoing high cholesterol, fatty liver, an enlarged liver, or unexplained liver disease starting in childhood or adulthood. It can also help confirm the cause of severe illness in babies.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it can tell you varies based on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may provide a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person than for another. These differences are common and can influence both how well a medicine works and how likely someone is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences shape a person’s response to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect either how strongly a drug works or how the body processes it. This information can support more informed, more individualized treatment decisions. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the LIPA gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, changes in treatment, or your overall health are best discussed with your doctor or pharmacist.
History
Throughout history, doctors described infants and children with unusual fat buildup in organs, long before the LIPA gene was identified. In 1956, pediatrician Moshe Wolman gave a detailed description of the severe early form of the condition that later became known as Wolman disease. A milder form, historically called cholesteryl ester storage disease, was recognized afterward in children and adults with liver problems and abnormal cholesterol levels. Initially understood only through visible traits, later recognized as tied to a specific gene, these conditions were eventually linked as part of the same spectrum. In the 1990s, researchers identified the LIPA gene and confirmed that changes in it explained both forms. These historical steps shaped today’s understanding of lysosomal acid lipase deficiency.